rs1187393388
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Specifically, our observation supports the association between the MSH6 c.2194C>T pathogenic variant and extracolonic tumours and it suggests that MSH6 pathogenic variants are associated with familial pancreatic cancer more frequently than assumed.
|
31851094 |
2020 |
rs587779930
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Specifically, our observation supports the association between the MSH6 c.2194C>T pathogenic variant and extracolonic tumours and it suggests that MSH6 pathogenic variants are associated with familial pancreatic cancer more frequently than assumed.
|
31851094 |
2020 |
rs63751127
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Specifically, our observation supports the association between the MSH6 c.2194C>T pathogenic variant and extracolonic tumours and it suggests that MSH6 pathogenic variants are associated with familial pancreatic cancer more frequently than assumed.
|
31851094 |
2020 |
rs4503083
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Familial pancreatic cancer was noted in 15 cases (19%) and comparison of the FPC cohort set to the genetic control set showed a 3-fold increase in Y359Stop homozygous rates (p = 0.054).
|
29426021 |
2018 |
rs1176026649
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The P239S palladin variant has recently been suggested to play a role in hereditary pancreatic cancer.
|
17415588 |
2007 |
rs11571833
|
|
|
0.010 |
GeneticVariation |
BEFREE |
One K3326X carrier with familial pancreatic cancer</span> carried an alteration (IVS 16-2A>G) suspected to be deleterious.
|
15806175 |
2005 |
rs486907
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results suggest that RNASEL variants Glu265X and Arg462Gln may contribute to the tumorigenesis of sporadic and familial pancreatic cancer, which has to be proven in large scale studies.
|
15981205 |
2005 |
rs74315364
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results suggest that RNASEL variants Glu265X and Arg462Gln may contribute to the tumorigenesis of sporadic and familial pancreatic cancer, which has to be proven in large scale studies.
|
15981205 |
2005 |
rs17107315
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.
|
14688470 |
2004 |